Jeil Pharma Holdings, Up 2.17% on COVID-19 (Nafamostat) Theme Rally

On the 22nd, the COVID-19 (Nafamostat) theme rose by 3.72% compared to the previous day, showing strength, while Jeil Pharma Holdings, which is attracting attention as a related stock, surged by 2.17% compared to the previous day. Jeil Pharma Holdings is known to have converted into a holding company in June 2017.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharma Holdings’ quant financial score is 23.26 points, with higher growth and stability scores than the average of other stocks related to COVID-19 (Nafamostat), but its quant financial ranking was only 7th out of 13 stocks. On the other hand, Chong Kun Dang Holdings ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top financial scores within the theme

※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.